1. Program in Cardiovascular and Metabolic Disorders, Duke–National University of Singapore Medical School, Singapore (S.C., S.S., E.A., S.V., A.W., S.L., M.W., G.D., S.G.S., B.L.G., S.L., E.Y.C., E.C., J.D., S.A.C., O.J.L.R.).
2. National Heart Centre Singapore, Singapore (S.S., S.L., J.T., C.J.P., S.A.C.).
3. Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (E.A., S.v.H., F.W., S.B., G.P., N.H.).
4. National Heart and Lung Institute, Imperial College London, United Kingdom (N.M.Q., L.E.F., P.J.R.B., S.A.C.).
5. Medical Research Council-London Institute of Medical Sciences, Hammersmith Hospital Campus, United Kingdom (N.M.Q, S.A.C.).
6. Cardiovascular Research Centre, Royal Brompton and Harefield National Health Serfice Trust, London, United Kingdom (N.M.Q, P.J.R.B.).
7. German Centre for Cardiovascular Research, partner site Berlin, Germany (N.H.).
8. Charité-Universitätsmedizin, Berlin, Germany (N.H.).
9. Berlin Institute of Health, Germany (N.H.).